ATE487800T1 - Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion - Google Patents
Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktionInfo
- Publication number
- ATE487800T1 ATE487800T1 AT06807950T AT06807950T ATE487800T1 AT E487800 T1 ATE487800 T1 AT E487800T1 AT 06807950 T AT06807950 T AT 06807950T AT 06807950 T AT06807950 T AT 06807950T AT E487800 T1 ATE487800 T1 AT E487800T1
- Authority
- AT
- Austria
- Prior art keywords
- ovarian
- ovarian function
- vitro detection
- presidency
- predisposition
- Prior art date
Links
- 230000002611 ovarian Effects 0.000 title abstract 4
- 238000001514 detection method Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000000338 in vitro Methods 0.000 title abstract 2
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 abstract 2
- 230000004075 alteration Effects 0.000 abstract 2
- 230000018109 developmental process Effects 0.000 abstract 2
- 206010036601 premature menopause Diseases 0.000 abstract 2
- 101000695360 Homo sapiens Bone morphogenetic protein 15 Proteins 0.000 abstract 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 230000009245 menopause Effects 0.000 abstract 1
- 102000054765 polymorphisms of proteins Human genes 0.000 abstract 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/362—Menopause
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Semiconductor Memories (AREA)
- Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200502225 | 2005-09-13 | ||
| PCT/ES2006/070130 WO2007031590A1 (es) | 2005-09-13 | 2006-08-29 | Método de detección in vitro de la predisposición a desarrollar alteraciones en la función ovárica |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE487800T1 true ATE487800T1 (de) | 2010-11-15 |
Family
ID=37864641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06807950T ATE487800T1 (de) | 2005-09-13 | 2006-08-29 | Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20100203502A1 (de) |
| EP (1) | EP1947195B1 (de) |
| AT (1) | ATE487800T1 (de) |
| DE (1) | DE602006018183D1 (de) |
| WO (1) | WO2007031590A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2416410C2 (ru) * | 2005-04-29 | 2011-04-20 | Ферринг Интернэшнл Сентер С.А. | Лечение или профилактика синдрома гиперстимуляции яичников (ohss) с использованием агониста дофамина |
| AU2010351560C1 (en) * | 2009-09-23 | 2015-10-08 | Celmatix Inc. | Methods and devices for assessing infertility and/or egg quality |
| US10162800B2 (en) | 2012-10-17 | 2018-12-25 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
| US9177098B2 (en) | 2012-10-17 | 2015-11-03 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
| US9836577B2 (en) | 2012-12-14 | 2017-12-05 | Celmatix, Inc. | Methods and devices for assessing risk of female infertility |
| KR20170063519A (ko) | 2014-07-17 | 2017-06-08 | 셀매틱스, 인크. | 불임 및 관련 병리상태를 평가하기 위한 방법 및 시스템 |
| US20170107573A1 (en) * | 2015-10-19 | 2017-04-20 | Celmatix Inc. | Methods and systems for assessing infertility as a result of declining ovarian reserve and function |
| AU2018214444A1 (en) * | 2017-02-01 | 2019-09-19 | Anlagen Pty Ltd | Gamete-secreted growth factors |
| WO2018200820A1 (en) * | 2017-04-26 | 2018-11-01 | Celmatix Inc. | A measurement system and method for defining and determining an ovarian reserve |
| CN110564839A (zh) * | 2019-08-23 | 2019-12-13 | 浙江大学 | 一种卵巢早衰相关基因全外显子扩增及检测方法 |
| CN111500723A (zh) * | 2020-04-28 | 2020-08-07 | 广州达康基因技术有限公司 | 一种用于卵巢早衰基因检测的标志物组合及检测试剂盒 |
| CN112266953B (zh) * | 2020-07-27 | 2022-08-02 | 广州达康基因技术有限公司 | 女性卵巢早衰易感基因检测模型及检测试剂盒 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002537776A (ja) * | 1999-02-25 | 2002-11-12 | オークランド ユニサーヴィスィズ リミテッド | 早発性卵巣機能不全の診断及び治療 |
| NZ500844A (en) * | 2000-05-05 | 2003-06-30 | Agres Ltd | Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate |
| NZ519330A (en) * | 2002-05-30 | 2004-12-24 | George Henry Davis | New sequences for altering mammalian ovarian function and ovulation rate |
-
2006
- 2006-08-29 EP EP06807950A patent/EP1947195B1/de not_active Not-in-force
- 2006-08-29 AT AT06807950T patent/ATE487800T1/de not_active IP Right Cessation
- 2006-08-29 DE DE602006018183T patent/DE602006018183D1/de active Active
- 2006-08-29 WO PCT/ES2006/070130 patent/WO2007031590A1/es not_active Ceased
- 2006-08-29 US US11/991,868 patent/US20100203502A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007031590A9 (es) | 2007-05-31 |
| EP1947195B1 (de) | 2010-11-10 |
| DE602006018183D1 (de) | 2010-12-23 |
| WO2007031590A1 (es) | 2007-03-22 |
| EP1947195A4 (de) | 2009-11-04 |
| EP1947195A1 (de) | 2008-07-23 |
| US20100203502A1 (en) | 2010-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE487800T1 (de) | Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion | |
| BR112013003391B8 (pt) | Método para diagnosticar câncer pancreático em um indivíduo | |
| Krajnak et al. | Characterization of frequency-dependent responses of the vascular system to repetitive vibration | |
| ATE452343T1 (de) | Verbesserte vitamin-d-messung | |
| ATE536553T1 (de) | Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse | |
| ATE450623T1 (de) | Modifikatoren der lichtemission und ihre verwendungen zur detektion, amplifikation und analyse von nukleinsäuren | |
| BR112014016313A2 (pt) | medições precisas de analito para tira de teste eletroquímico com base em característica(s) física(s) detectada(s) da amostra contendo o analito e parâmetros de biossensores derivados | |
| DE602006012839D1 (de) | Vorbehandlung einer biologischen probe aus einem individuum mit autoimmunkrankheit | |
| CY1107490T1 (el) | Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου | |
| EP2212700B8 (de) | Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex | |
| WO2019139980A8 (en) | Methods for measuring analyte and/or protein in biological samples | |
| WO2006069023A3 (en) | Assay method and apparatus with reduced sample matrix effects | |
| BRPI0514197A (pt) | método de impressão de um indicador de tempo-temperatura baseado em reações de azoacoplamento sobre um substrato | |
| TW200641366A (en) | Apparatus, program, and method for substrate inspection | |
| ATE489622T1 (de) | Verfahren zur beurteilung der malignität einer säuger-krebszelle | |
| WO2009140390A3 (en) | Serum markers for type ii diabetes mellitus | |
| BRPI0515325A (pt) | processo para simular os efeitos corrosivos dos estoques de provisão de refinaria sobre a metalurgia de refinaria | |
| BRPI0410988A (pt) | processo e dispositivo para análise quantitativa de soluções e dispersões por meio de espectroscopia de infravermelho próximo | |
| NO20080294L (no) | Fremgangsmate for a pavise en drivstoffadditivkomponent | |
| FR2900936B1 (fr) | Procede et methodes de detection de la maladie d'alzheimer | |
| WO2021138273A3 (en) | Autoantibodies as biomarkers for autoimmune polyglandular syndrome type 1 | |
| WO2008057767A3 (en) | Reduction of non-specific binding in immunoassays | |
| DE60012723D1 (de) | Verfahren zur bestimmung von disaccharidasen | |
| EP4350355A3 (de) | Verbesserter assay | |
| BRPI0914298A2 (pt) | processo imunocromatográfico e sistema de teste para a determinação de, pelo menos, um analito em uma solução de teste a ser analisada |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |